Elsevier

Toxicology

Volume 288, Issues 1–3, 9 October 2011, Pages 49-55
Toxicology

cAMP production mediated through P2Y11-like receptors in rat striatum due to severe, but not moderate, carbon monoxide poisoning

https://doi.org/10.1016/j.tox.2011.07.001Get rights and content

Abstract

We examined the effect of carbon monoxide (CO) poisoning on the production of cAMP, an intracellular second messenger, in rat striatum in terms of extracellular cAMP, which is highly correlated with intracellular cAMP, by using microdialysis. Severe poisoning due to 3000 ppm CO, but not moderate poisoning due to 1000 ppm CO, caused an increase in cAMP, which was susceptible to a voltage-dependent Na+ channel blocker, tetrodotoxin, and more profound than that under comparable hypoxia caused by 5% O2. These results were similar to our previous findings on the production of hydroxyl radical (OH), suggesting a close relationship between cAMP and OH production. The increase in cAMP was suppressed by a non-selective purine P2 receptor antagonist, suramin. However, other non-selective P2 receptor antagonists, pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid and reactive blue 2, exhibited no effect and weak non-significant suppression, respectively. A P2Y11 receptor antagonist, NF157, dose-dependently suppressed the increase in cAMP, although rats lack the P2Y11 receptor. These results suggest that a threshold for cAMP production mediated through P2Y11-like receptors following depolarization triggered by Na+ influx exists in rat striatum during CO poisoning, and that the threshold is reached only in cases of severe CO poisoning. It is also likely that the threshold is related to the generation of OH, contributing to the toxicity of CO in the brain.

Highlights

► A threshold for stimulation of striatal cAMP production in CO poisoning. ► Close relationship between cAMP and hydroxyl radical production in CO poisoning. ► CO-induced cAMP production mediated by P2Y11-like receptors.

Introduction

Carbon monoxide (CO) is well known as a toxic gas, which binds to hemoglobin more strongly than does O2, forming carboxyhemoglobin (COHb) and interfering with the supply of O2 to tissues. Therefore, the brain, which strongly demands O2 to function, is vulnerable to CO poisoning. Injuries in the brain are salient in the cerebral cortex, globus pallidus, hippocampus, and caudate putamen, accompanying neuropsychological disorders, such as parkinsonism and amnesia, in humans (Choi and Cheon, 1999, Gale et al., 1999, Ginsberg, 1980, O’Donnell et al., 2000) and experimental animals (Ishimaru et al., 1992, Nabeshima et al., 1991). We found that CO poisoning stimulated generation of hydroxyl radical (OH), the most toxic of the reactive oxygen species (ROS), in rat striatum (Hara et al., 2004), which could play a role in brain injury due to CO poisoning as well as brain ischemia and trauma (Gilgun-Sherki et al., 2002, Leker and Shohami, 2002, Lewén et al., 2000). Interestingly, OH production was evident in rats with over 70% COHb due to 3000 ppm CO, but not those with approximately 50% COHb due to 1000 ppm CO, suggesting that severe, though not moderate, CO poisoning stimulates the generation of OH (Hara et al., 2011). Therefore, a threshold is likely to exist for CO-induced OH production.

An increase in an intracellular second messenger, cAMP, in the brain is a well-recognized event in response to brain ischemia and hypoxia/anoxia (Palmer, 1985). The increase could be attributed to activation of adenylate cyclase mediated through a stimulatory guanine nucleotide-binding protein (Gs) coupled with receptors of various neurotransmitters and neuromodulators, including dopamine, noradrenaline, serotonin (5-HT), histamine, adenosine and prostaglandins (Tanaka, 2001), which are increased in the extracellular fluid in response to brain insults (Adachi, 2005, Cheng et al., 2000, Hagberg et al., 1987, Stevens and Yaksh, 1988, Thaminy et al., 1997, Yang et al., 2007). Prado et al. (1992) reported that the cAMP increase in rat striatum due to brain ischemia was attenuated by SCH23390, an antagonist of the DA receptors coupled to Gs (Missale et al., 1998). The antagonist also attenuated striatal damage following brain ischemia in newborn piglets (Yang et al., 2007). Therefore, activation of the cAMP signaling pathways mediated through the dopamine system might at least in part play a deleterious role in the brain damage (Prado et al., 1992, Yang et al., 2007). In addition, Tsukada et al. (2004) suggested that the cAMP signaling pathways mediated through 5-HT1A receptors as well as the dopamine receptors are involved in ischemic brain damage in monkeys. On the other hand, studies have proposed that activation of the cAMP pathway protects against ischemic brain damage (Tanaka, 2001). This is supported by the protective effect of rolipram and cilostazol, which increase intracellular cAMP levels by inhibiting phosphodiesterases (Block et al., 1997, Choi et al., 2002). Furthermore, pretreatment with a cell-permeable cAMP analogue, dibutyryl cAMP (db-cAMP) (Qiu et al., 2002), as well as phosphodiesterase inhibitors (Nikulina et al., 2004), promotes axonal regeneration in animal models of spinal cord lesions. However, direct administration of db-cAMP to the brain elicits seizures (Kuriyama and Kakita, 1980), which could lead to neural injury (Berg et al., 1993). In fact, Amadio et al. (2005) reported cell death induced by forskolin (a direct activator of adenylate cyclase), 3-isobutyl-1-methyl-xanthine (a phosphodiesterase inhibitor) and (4-chloro phenylthio)-cAMP (a cAMP analogue) in cultured cerebellar granule neurons. In these neurons, stimulation of purine receptors by an ATP analogue, ATPγS, enhanced both cAMP and ROS production (Amadio et al., 2005). In addition, direct administration of ATP to rat striatum was injurious (Ryu et al., 2002). Thus, it is likely that the cAMP signaling system has paradoxical functions in the brain.

It is known that intracellular production of cAMP is highly correlated with the efflux of cAMP to the extracellular space (Egawa et al., 1988, Rosenberg and Li, 1995), which can be monitored in the brain in vivo by microdialysis (Egawa et al., 1988, Hashimoto and Kuriyama, 1997, Klamer et al., 2005, Wade et al., 2004). In the present study, we found that the extracellular cAMP level was increased in the striatum of rats exposed to CO at 3000 ppm, but not 1000 ppm, as in the case of OH production. It is likely that cAMP is a factor associated with the threshold of CO-induced OH generation. Therefore, we explored the mechanism of increase in cAMP.

Section snippets

Animals

Male Sprague-Dawley rats, weighing 235–265 g, were purchased from Charles River Laboratories Japan (Kanagawa, Japan). Animals were acclimated with free access to food and water in a facility with controlled temperature (22–24 °C) on a 12-h/12-h light/dark cycle (lights on between 08:00 and 20:00 h), for at least one week before all of the experiments.

The experimental protocol of this work was approved by the Institutional Animal Care and Use Committee (IACUC) of Tokyo Medical University and all

Effect of CO and non-CO hypoxia on extracellular cAMP levels in rat striatum

Exposure to CO at 1000 ppm for 40 min had no effect on extracellular cAMP levels in the striatum. However, CO at 3000 ppm significantly increased it at 40 min (at the end of the exposure), 60 min and 80 min (20 min and 40 min after the exposure, respectively), although the last increase was less remarkable (Fig. 1). In the case of non-CO hypoxia caused by 5% O2, the increase in cAMP was significant at 20 min of exposure and reached a peak at 40 min of exposure (at the end of exposure) (Fig. 1). To

Discussion

In the present study, we demonstrated that extracellular cAMP levels were increased in the striatum of rats exposed to 3000 ppm of CO, which causes acute CO poisoning with over 70% COHb (Hara et al., 2002, Hara et al., 2011). This indicates that CO poisoning, as well as brain ischemia and hypoxia (Palmer, 1985), enhances cAMP production in the striatum. It is of interest that 1000 ppm CO did not exhibit this ability, with COHb reaching approximately 50% (Hara et al., 2002, Hara et al., 2011). In

Conflicts of interest

There are none.

Role of the funding source

This study was supported by a Grant-in-Aid for Scientific Research (C) (21590747) from the Ministry of Education, Science, Sports and Culture, Japan.

References (54)

  • P. O’Donnell et al.

    The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning

    Clin. Radiol.

    (2000)
  • M. Okada et al.

    Interaction between purinoceptor subtypes on hippocampal serotonergic transmission using in vivo microdialysis

    Neuropharmacology

    (1999)
  • J. Olcese et al.

    Effects of para-chlorophenylalanine, a brain serotonin depletor, on pituitary cyclic AMP levels in the rainbow trout, Salmo gairdneri

    Gen. Comp. Endocrinol.

    (1981)
  • G.C. Palmer

    Cyclic nucleotides in stroke and related cerebrovascular disorders

    Life Sci.

    (1985)
  • J. Qiu et al.

    Spinal axon regeneration induced by elevation of cyclic AMP

    Neuron

    (2002)
  • P.A. Rosenberg et al.

    Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex

    Brain Res.

    (1995)
  • H. Shimizu et al.

    Effect of depolarizing agents on accumulation of cyclic adenosine 3′,5′-monophosphate in cerebral cortical slices

    Eur. J. Pharmacol.

    (1972)
  • K. Tanaka

    Alteration of second messengers during acute cerebral ischemia – adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein

    Prog. Neurobiol.

    (2001)
  • S. Thaminy et al.

    Is chlormethiazole neuroprotective in experimental global cerebral ischemia?.: a microdialysis and behavioral study

    Pharmacol. Biochem. Behav.

    (1997)
  • I. Von Kügelgen

    Pharmacological profiles of cloned mammalian P2Y-receptor subtypes

    Pharmacol. Ther.

    (2006)
  • M.R. Wade et al.

    Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study

    Brain Res.

    (2004)
  • G.G. Yegutkin et al.

    Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes

    Biochim. Biophys. Acta

    (2000)
  • M. Berg et al.

    Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists

    Pharmacol. Toxicol.

    (1993)
  • F. Block et al.

    Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats

    Neuroreport

    (1997)
  • F.C. Cheng et al.

    A dual-probe microdialysis study in simultaneously monitoring extracellular pyruvate, lactate, and biogenic amines in gerbil striata during unilateral cerebral ischemia

    Neurochem. Res.

    (2000)
  • I.S. Choi et al.

    Delayed movement disorders after carbon monoxide poisoning

    Eur. Neurol.

    (1999)
  • J.M. Choi et al.

    Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats

    J. Pharmacol. Exp. Ther.

    (2002)
  • Cited by (13)

    • Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease

      2023, Neuropharmacology
      Citation Excerpt :

      Sleep alterations are included in the criteria for diagnosing major depressive disorders since they are frequent symptoms of these patients. Depending on the duration, sleep deprivation may either impair memory consolidation (Gvilia et al., 2017) or induce short-term antidepressant effects (Borbély, 1987). Not surprisingly, depression and sleep disorders are frequent comorbidities of AD.

    • Hydroxyl radical production via NADPH oxidase in rat striatum due to carbon monoxide poisoning

      2018, Toxicology
      Citation Excerpt :

      The CO-induced OH production in rat striatum is strongly suppressed by NADPH oxidase (NOX) inhibitors, diphenyleneiodonium (DPI; strong but nonselective) and 4-(2-aminoethyl) benzenesulfonylfluoride (AEBSF; weaker but more selective than DPI), but not a xanthine oxidase (XO) inhibitor, allopurinol (Hara et al., 2014). In addition, the CO-induced OH production parallels cAMP production, which might be mediated through a purinergic 2Y (P2Y) receptor similar to the P2Y11 receptor stimulatory for cAMP production (Hara et al., 2011a), although the P2Y11 receptor has not been found in rodents (von Kügelgen, 2006). The NOX family consists of NOX1 through NOX5 (NOX5 has not been found in rodents) and dual oxidase 1 (DUOX1) and DUOX2 (Altenhöfer et al., 2015).

    • Dual contradictory roles of cAMP signaling pathways in hydroxyl radical production in the rat striatum

      2012, Free Radical Biology and Medicine
      Citation Excerpt :

      Studies have indicated that the components of the cAMP signaling system are subcellularly compartmentalized and are organized and diversely regulated in response to individual signals [36,37]. We further explored the roles of the cAMP signaling pathways in the enhanced production of hydroxyl radicals that occurred concomitant with the production of cAMP during CO poisoning [24,25]. The CO-induced production of hydroxyl radicals was potentiated by H89, which was also observed in the cases of the cAMP mimetics and forskolin.

    View all citing articles on Scopus
    View full text